A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
NCT01311050 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2011-12-13
Summary
A Phase I-II Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination with Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Conditions
Interventions
- DRUG
-
Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab
Capecitabine (Xeloda), Oxaliplatin, Irinotecan, Bevacizumab
Sponsors & Collaborators
-
King Faisal Specialist Hospital & Research Center
lead OTHER
Principal Investigators
-
Shouki Bazarbashi, M.D. · KFSH & RC
Eligibility
- Min Age
- 14 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer
NCT00159432 ·Status: COMPLETED ·Phase: PHASE2
-
Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
NCT00290615 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
NCT00220116 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT00642603 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.
NCT01067053 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal Cancer
NCT01531595 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer
NCT04324476 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer
NCT00177307 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer
NCT00220051 ·Status: COMPLETED ·Phase: PHASE2
-
Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer
NCT01024504 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
NCT00069095 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.
NCT01159171 ·Status: COMPLETED ·Phase: PHASE2
-
S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer
NCT00118105 ·Status: WITHDRAWN ·Phase: PHASE2
-
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
NCT00433550 ·Status: COMPLETED ·Phase: PHASE2
-
Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer
NCT00118261 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer
NCT00345761 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
NCT00114231 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC
NCT04508452 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
NCT00202774 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III
NCT01196260 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
NCT00087334 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer
NCT00296062 ·Status: TERMINATED ·Phase: PHASE1
-
Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer
NCT06405139 ·Status: RECRUITING ·Phase: PHASE2
-
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
NCT00022698 ·Status: COMPLETED ·Phase: PHASE2
-
2nd-line Treatment of Metastatic Colorectal Cancer
NCT01532804 ·Status: TERMINATED ·Phase: PHASE2